ARCHIVES

Multi-Gene Assay Predicts Recurrence In Newly Diagnosed Breast Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: EU approves Imbruvica in MCL, CLL

October 24, 2014

European regulators plan more rigorous rules for accelerated approval in cancer.

November 11, 2005

Time-Out For A New Sense Of Cooperation, Urgency.

January 21, 2000

ASCO, AACR Honor Scientists, Journalists At Annual Meetings

May 29, 1992

The 99th turned Out Well For Cancer Program, But Several Important Issues Await 100th Congress

October 31, 1986

OMB Reprogramming Ban Criticized

September 20, 1985